Yahoo · Oct 29, 2026
BTSG Ahead of Q3 Earnings: Can Growth Offset Ongoing IRA Risks?
BrightSpring gears up for Q3 earnings, with strong Specialty, Infusion and Provider Services growth expected to offset IRA headwinds. Can it beat estimates?
NYSE · BTSGU
Healthcare · Medical - Healthcare Information Services
$218.59
Up+$6.34 (+2.90%)
Updated Nov 3, 2026, 9:36 PM
SID Score
5.7/10
Composite research score
Smart Money
58/100
Neutral
Price performance · BTSGU
1M range · 17 trading sessions · Daily adjusted prices
Prices through Nov 2, 2026
BTSGU closed at $218.59 after 17 trading sessions, up 3.65% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 2, 2026 | $218.18 | $218.59 | $215.14 | $218.59 | 127.45K |
| Oct 30, 2026 | $223.41 | $223.41 | $207.795 | $218.16 | 23.74K |
| Oct 29, 2026 | $202.08 | $202.70 | $198.30 | $198.30 | 5.91K |
| Oct 28, 2026 | $193.18 | $195.24 | $191.52 | $195.18 | 4.04K |
| Oct 27, 2026 | $192.46 | $192.46 | $190.93 | $191.91 | 2.15K |
| Oct 26, 2026 | $192.655 | $192.705 | $192.59 | $192.59 | 2.38K |
| Oct 23, 2026 | $197.83 | $197.83 | $197.83 | $197.83 | 947 |
| Oct 22, 2026 | $197.19 | $197.19 | $197.19 | $197.19 | 635 |
| Oct 21, 2026 | $206.06 | $207.52 | $206.06 | $207.52 | 648 |
| Oct 20, 2026 | $202.46 | $205.04 | $202.46 | $204.97 | 566 |
| Oct 19, 2026 | $201.58 | $201.58 | $201.58 | $201.58 | 626 |
| Oct 16, 2026 | $200.22 | $200.22 | $186.00 | $197.90 | 1.31K |
| Oct 15, 2026 | $206.73 | $206.73 | $203.26 | $205.42 | 20.37K |
| Oct 14, 2026 | $208.63 | $208.63 | $208.09 | $208.09 | 831 |
| Oct 13, 2026 | $204.75 | $205.04 | $204.4304 | $204.4304 | 1.91K |
| Oct 12, 2026 | $206.44 | $206.66 | $206.01 | $206.66 | 712.05 |
| Oct 8, 2026 | $207.10 | $211.79 | $207.10 | $210.90 | 734 |
The latest Smart Investors Daily articles mentioning BTSGU.
Company
Market Activity
Research & News
BTSGU research
Company profile and research snapshot.
BrightSpring Health Services Inc is a home and community-based healthcare services platform, focused on delivering complementary pharmacy and provider services to complex patients. Its platform delivers clinical services and pharmacy solutions across Medicare, Medicaid, and commercially insured populations. Its segments include Pharmacy Solutions, Provider Services, and others. It generates the majority of its revenue from the Pharmacy Solutions segment.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Nov 3, 2026 | Guggenheim | Buy | — |
| Nov 2, 2026 | Wells Fargo | Overweight | — |
| Nov 2, 2026 | UBS | Buy | — |
| Nov 2, 2026 | TD Cowen | Buy | — |
| Nov 2, 2026 | Leerink Partners | Outperform | — |
No generated briefing is available yet.
Yahoo · Oct 29, 2026
BrightSpring gears up for Q3 earnings, with strong Specialty, Infusion and Provider Services growth expected to offset IRA headwinds. Can it beat estimates?
Yahoo · Oct 29, 2026
Healthcare services provider BrightSpring Health Services (NASDAQ:BTSG) will be announcing earnings results this Friday before the bell. Here’s what to expect.
Yahoo · Aug 24, 2026
As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the senior health, home health & hospice industry, including BrightSpring Health Services (NASDAQ:BTSG) and its peers.
SeekingAlpha · Jul 31, 2026
BrightSpring Health Services, Inc. (BTSG) Q2 2026 Earnings Call July 31, 2026 8:30 AM EDTCompany ParticipantsJon Rousseau - Chairman, President &...
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning BTSGU.